1. Abrams JR, Lebwohl MG, Guzzo CA, et al: CTLA41g-mediated blockade of T cell costimulation in patients with psoriasis vulgaris. J Clin Invest, in press
2. Ahsan AA, Gottlieb AB, Sherr A, et al: Phase I trial of psoriasis with an anti-CD11A (LFA-1) monoclonal antibody (MAB) [abstract 478]. In Poster Abstract-Book, 57th Annual Meeting of the American Academy of Dermatology, New Orleans, LA, 1999
3. Ambroziak M, Stapor W, Langner: Tacalcitol in the treatment of extended psoriasis [abstract 483]. In Poster Abstract Book, 57th Annual Meeting of the American Academy of Dermatology, 1999
4. Interleukin 10 treatment of psoriasis: Clinical results of a phase 2 trial;Asadullah;Arch Dermatol,1999
5. Administration of DAB389IL-2 to patients with recalcitrant psoriasis: A double-blind, phase II multicenter trial;Bagel;J Am Acad Dermatol,1998